The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
Filter by category
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Filter by category
Poster
28/03/2023
Antitumor activity comparison of two somatostatin receptor ligands radiolabeled with Lutetium-177 (SSO110 and DOTA-TATE)
Somatostatin Receptor ligands Antitumor Activity comparison radiolabeled with Lutetium 177 alone or combined with chemotherapy in mice. Learn more here
Congress
14/03/2023
AACR Annual Meeting 2023
The AACR Annual Meeting brings together scientists, clinicians, and other professionals to share the latest advances in cancer science. Learn more here
Scientific publication
06/03/2023
Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases
New study investigates Pharmacological Inhibitors of DYRK and CLK Protein Kinases and their comparative efficacy and selectivity. Learn more here
Scientific publication
02/03/2023
A Rhenium(I)-Diselenoether Compound Significantly Decreased the Viral Load of SARS-CoV-2 in Infected Pulmonary Cells
Rhenium(I) tricarbonyl complexes inhibited the 3- chymotrypsin-like protease (3CLpro) which is one of the main proteases of the severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2 virus), but the antiviral effect was not studied.
Scientific resource
21/02/2023
IBD Case study
Discover an example of a screening cascade developed by Oncodesign Services that led to the identification of preclinical candidates.
Congress
21/02/2023
Oncodesign Services Events in March 2023
Oncodesign is taking part in many events this March. Here is a short selection of where we are travelling over the next few weeks. Learn more here
10/02/2023
The International Day of Women and Girls in Science
We met with women employees of Oncodesign Services to talk their careers and their ambitions for a better valorization of women in Science. Learn more here
Blog
02/02/2023
Why do preclinical cancer models still fail in the clinic?
We at Oncodesign Services strive to develop alternative Preclinical Cancer Models to better suit your drug development. Read more about our solutions here.
News
19/01/2023
Oncodesign S.A. is now Oncodesign Services S.A.
Oncodesign Services is chane announced the change of name to Oncodesign Services and a new COMEX for 2023.
Scientific publication
16/01/2023
Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer
Liposomal Irinotecan is hypothesized to have a higher therapeutic index than its non-liposomal counterpart in mice with Pancreatic Cancer. Read more here.
News
14/12/2022
Oncodesign Services looks to the future
As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future
Scientific publication
25/11/2022
Calcium(II)-Catalyzed Chemoselective and Regioselective Epoxide Ring-Opening with NH Sulfoximines
In this paper we describe methods for the Organic Synthesis of 1,2-sulfoximidoyl ethanols thanks to an Epoxide Ring Opening with NH Sulfoximines. Read more.